IPSEN (OTCMKTS:IPSEY – Get Free Report) was the recipient of a significant growth in short interest during the month of June. As of June 15th, there was short interest totaling 143 shares, a growth of 286.5% from the May 31st total of 37 shares. Currently, 0.0% of the company’s stock are sold short. Based on an average trading volume of 568 shares, the days-to-cover ratio is presently 0.3 days.
IPSEN Stock Performance
Shares of OTCMKTS:IPSEY remained flat at $46.50 during midday trading on Friday. The stock had a trading volume of 42 shares, compared to its average volume of 578. The stock’s fifty day moving average is $47.34 and its 200 day moving average is $43.66. IPSEN has a 12 month low of $29.05 and a 12 month high of $51.10.
Wall Street Analyst Weigh In
Several analysts have commented on IPSEY shares. Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of IPSEN in a research report on Thursday, May 14th. HC Wainwright assumed coverage on shares of IPSEN in a report on Friday, June 5th. They issued a “buy” rating for the company. Finally, Zacks Research raised shares of IPSEN to a “hold” rating in a research report on Friday, May 29th. Two analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold”.
About IPSEN
Ipsen is a global biopharmaceutical company headquartered in Boulogne-Billancourt, France. Founded in 1929, the company focuses on specialty care areas including oncology, neuroscience and rare diseases. Ipsen develops, manufactures and commercializes innovative medicines that address critical unmet medical needs, offering a diverse portfolio of therapies for both adult and pediatric patient populations.
The company’s oncology franchise includes treatments for prostate, renal and hepatocellular carcinomas, with key products such as Cabometyx (cabozantinib) and Decapeptyl (triptorelin).
Featured Articles
- Five stocks we like better than IPSEN
- 3 Stocks That Could Benefit as the Robotaxi Race Heats Up
- 3 Waste Stocks Turning AI Investments into Growth
- 3 Overlooked Tech ETFs That Are Quietly Killing It This Year
- 3 ETFs Pairing Market-Beating Returns With High Dividend Yields
Receive News & Ratings for IPSEN Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IPSEN and related companies with MarketBeat.com's FREE daily email newsletter.
